ReviewFrontiers in psychiatry2026
Exercise-induced anandamide-CB1R signaling and prefrontal-amygdala stress circuits in adolescent depression: a critical hypothesis-driven narrative review.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adolescent depression emerges during a developmental period characterized by ongoing maturation of corticolimbic and stress-regulatory systems. This narrative review critically evaluates a hypothesis that acute exercise-related endocannabinoid mobilization, particularly changes in circulating anandamide (AEA), may be linked to CB1 receptor (CB1R)-dependent processes relevant to prefrontal-amygdala function and stress-sensitive symptom dimensions. The evidence base is fragmented across populations and experimental levels. Human exercise studies, conducted predominantly in healthy adults, indicate that acute aerobic exercise can increase circulating AEA, but peripheral AEA cannot be assumed to reflect AEA concentrations or CB1R engagement within the prefrontal cortex or amygdala. Separately, preclinical and translational studies show that endocannabinoid signaling can modulate presynaptic transmission, stress-related responses, and fear learning in a region-, cell-type-, and ligand-dependent manner. Neuroimaging studies implicate altered prefrontal-amygdala connectivity in some adolescents with depression, although findings vary across tasks, subregions, samples, and analytic approaches. Critically, no study has tested the complete sequence linking exercise, AEA responses, CB1R-dependent signaling, prefrontal-amygdala circuit change, and depressive symptom improvement in adolescents. We therefore treat this sequence as an unvalidated cross-level model rather than a demonstrated causal pathway. This review distinguishes direct from indirect evidence, examines conflicting findings, considers developmental and sex-related moderators, and proposes experiments that integrate exercise dose, circulating AEA and 2-arachidonoylglycerol, FAAH-related biology, circuit-level outcomes, and symptoms. The proposed framework is most appropriately viewed as a testable model for stress-sensitive and emotion-regulation-related symptom dimensions rather than an established antidepressant mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.